Vitamin B12 Injection
Function and Efficacy
This product is an anti-anemia drug. Vitamin B12 participates in methyl conversion and folic acid metabolism in the body, and promotes the conversion of 5-methyltetrahydrofolate into tetrahydrofolate. When it is deficient, it leads to DNA synthesis disorders and affects the maturation of red blood cells. This product also promotes the conversion of methylmalonic acid into succinic acid and participates in the tricarboxylic acid cycle. This effect is related to the synthesis of nerve myelin lipids and the maintenance of the integrity of myelinated nerve fiber function. The nerve damage caused by vitamin B12 deficiency may be related to this.
Ingredients
The main ingredient of this product is vitamin B12
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Vitamin B12Ingredients |
This product is an anti-anemia drug. Vitamin B12 participates in methyl conversion and folic acid metabolism in the body, and promotes the conversion of 5-methyltetrahydrofolate into tetrahydrofolate. When it is deficient, it leads to DNA synthesis disorders and affects the maturation of red blood cells. This product also promotes the conversion of methylmalonic acid into succinic acid and participates in the tricarboxylic acid cycle. This effect is related to the synthesis of nerve myelin lipids and the maintenance of the integrity of myelinated nerve fiber function. The nerve damage caused by vitamin B12 deficiency may be related to this. More |
68-19-9 | 16 |
Appearance
This product is a pink to red clear liquid, odorless and tasteless.
Indication
It is mainly used for megaloblastic anemia and can also be used as an adjuvant treatment for neuritis.
Usage and Dosage
Intramuscular injection, adults, 0.025-0.1 mg per day or 0.05-0.2 mg every other day. When used for neuritis, the dosage can be increased as appropriate.
Adverse Reactions
Intramuscular injection may occasionally cause rash, itching, diarrhea and allergic asthma, but the incidence is low, and anaphylactic shock may occur in very rare cases.
Precautions
Not yet clear
Special Population Medication
Precautions for children: Intramuscular injection of 25-100 μg/time, once a day or every other day. Avoid repeated administration to the same site, and be especially careful with newborns, premature infants, infants, and young children. Precautions for pregnancy and lactation: There is no research data on the safety and effectiveness of this product in pregnant and lactating women. Precautions for the elderly: There is no research data on the safety and effectiveness of this product in the elderly.
Drug Interactions
Aminosalicylic acid may weaken the effect of this product.
Storage
Too high a temperature or too long a disinfection time may cause it to decompose, so it should be kept in a sealed container away from light.
Packaging Specification
1ml:0.5mg
Validity Period
36 months
Manufacturer
Shanxi JINXIN DOUBLE-CRANE Pharmaceutical Co., Ltd.
-
Founded in:
2001-12-14 -
Address:
Sanlidun, North of Xia County, Yuncheng City, Shanxi Province -
Tax NO.:
911408287281430205 -
Registered Funds:
164.191 million yuan -
Website:
-
Email: